Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle-Invasive Bladder Cancer: Elective and Eligibility Factors Impacting Utilization.

Hiten D Patel,Ushasi Naha,Victor S Chen,Caitlyn Ko,Rachel Yang,Aleksander Druck,Goran Rac,Jeffrey L Ellis,Gopal N Gupta,Michael E Woods,Alex Gorbonos,Robert Flanigan,Marcus L Quek

Urology practice（2023）

引用 0|浏览7

暂无评分

摘要

NAC utilization increased over time with 85.7% of eligible patients with MIBC receiving NAC in recent years. Renal dysfunction, patient preference, and clinical contraindications were primary etiologies for lack of NAC. Fewer patients refused NAC in recent years leading to a potential ceiling for NAC utilization.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要